We now show that a two-gene methylation panel (ADAMTS1 and/or BNC1) demonstrated significant improvement in the detection rate, showing an even higher rate of positivity in stage I and stage II cancers (100% and 94.4%, respectively). Here, ADAMTS1 is linked to cancer.